august 24 2025 glp-1 drugs have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't GLP-1 Receptor Agonists in Hidradenitis

NHPN-1010 promoted functional normalization from noise-induced hearing loss as reflected in electrophysiological measures With pre-exposure measurements serving as the baseline, auditory sensitivity was evaluated by ABR recordings following noise exposure and subsequent treatment in the chronic phase

Current evidence suggests that a 20% increase in Firmicutes , accompanied by a proportional decrease in Bacteroidetes , may be associated with an estimated increase of approximately 150 kcal in daily energy harvest, potentially facilitating long-term weight gain (75)

If you were prescribed Ozempic and want to switch to a different medication, talk to your provider

1): (1) Rats in the normal control group got normal saline (0.9 % w/v, subcutaneously (s.c.)) once weekly for three weeks straight

The moment you have access to in-date insulin, switch to it

This triple mechanism explains why people taking GLP-1 therapy typically experience sustained appetite suppression and gradual, consistent weight loss over months